Predictive factors of histological response of colorectal liver metastases after neoadjuvant chemotherapy

被引:0
|
作者
Chloé Serayssol [1 ]
Charlotte Maulat [1 ]
Florence Breibach [2 ]
Fatima-Zohra Mokrane [3 ]
Janick Selves [2 ]
Rosine Guimbaud [4 ]
Philippe Otal [3 ]
Bertrand Suc [1 ]
Emilie Berard [5 ]
Fabrice Muscari [1 ]
机构
[1] Department of Digestive Surgery and Liver Transplantation, Toulouse-Rangueil University Hospital
[2] Department of Pathology, Toulouse University Hospital
[3] Department of Radiology, Toulouse-Rangueil University Hospital
[4] Department of Oncology, Toulouse-Rangueil University Hospital
[5] The Toulouse Research Methodology Support Unit, Toulouse University Hospital
关键词
Colorectal liver metastasis; Tumor regression grade; Neoadjuvant chemotherapy; Liver surgery; Histological response; Hepatectomy;
D O I
暂无
中图分类号
R735.34 [];
学科分类号
100214 ;
摘要
BACKGROUND Colorectal cancer is the third most common cancer in men and the second most common in women worldwide. Almost a third of the patients has or will develop liver metastases. Neoadjuvant chemotherapy(NAC) has recently become nearly systematic prior to surgery of colorectal livers metastases(CRLMs). The response to NAC is evaluated by radiological imaging according to morphological criteria.More recently, the response to NAC has been evaluated based on histological criteria of the resected specimen. The most often used score is the tumor regression grade(TRG), which considers the necrosis, fibrosis, and number of viable tumor cells.AIM To analyze the predictive factors of the histological response, according to the TRG, on CRLM surgery performed after NAC.METHODSFrom January 2006 to December 2013, 150 patients who had underwent surgery for CRLMs after NAC were included. The patients were separated into two groups based on their histological response, according to Rubbia-Brandt TRG.Based on their TRG, each patient was either assigned to the responder(R) group(TRG 1, 2, and 3) or to the non-responder(NR) group(TRG 4 and 5). All of the histology slides were re-evaluated in a blind manner by the same specialized pathologist. Univariate and multivariate analyses were performed.RESULTS Seventy-four patients were classified as responders and 76 as non-responders.The postoperative mortality rate was 0.7%, with a complication rate of 38%.Multivariate analysis identified five predictive factors of histological response.Three were predictive of non-response: More than seven NAC sessions, the absence of a radiological response after NAC, and a repeat hepatectomy(P <0.005). Two were predictive of a good response: A rectal origin of the primary tumor and a liver-first strategy(P < 0.005). The overall survival was 57% at 3 yr and 36% at 5 yr. The disease-free survival rates were 14% at 3 yr and 11% at 5 yr.The factors contributing to a poor prognosis for disease-free survival were: No histological response after NAC, largest metastasis > 3 cm, more than three preoperative metastases, R1 resection, and the use of a targeted therapy with NAC(P < 0.005).CONCLUSION A non-radiological response and a number of NAC sessions > 7 are the two most pertinent predictive factors of non-histological response(TRG 4 or 5).
引用
收藏
页码:295 / 309
页数:15
相关论文
共 50 条
  • [1] Predictive factors of histological response of colorectal liver metastases after neoadjuvant chemotherapy
    Serayssol, Chloe
    Maulat, Charlotte
    Breibach, Florence
    Mokrane, Fatima-Zohra
    Selves, Janick
    Guimbaud, Rosine
    Otal, Philippe
    Suc, Bertrand
    Berard, Emilie
    Muscari, Fabrice
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2019, 11 (04) : 295 - 309
  • [2] NEOADJUVANT TREATMENT OF LIVER METASTASES OF COLORECTAL CANCER: PREDICTIVE FACTORS OF PATHOLOGICAL RESPONSE
    Khessairi, Nayssem
    Mallek, Ines
    Mbarek, Mehdi
    Zaafouri, Elmontassar Belleh
    Gharbi, Lassaad
    Boufaroua, Ahlem Lahmar
    Bacha, Dhouha
    Ben-Slama, Sana
    ABCD-ARQUIVOS BRASILEIROS DE CIRURGIA DIGESTIVA-BRAZILIAN ARCHIVES OF DIGESTIVE SURGERY, 2024, 37
  • [3] Hepatectomy for colorectal liver metastases after neoadjuvant chemotherapy
    Brouquet, Antoine
    Benoist, Stephane
    BULLETIN DU CANCER, 2011, 98 (01) : 11 - 18
  • [4] Histological tumor response to neoadjuvant chemotherapy correlates to Immunoscore in colorectal cancer liver metastases patients
    Zhang, Chong
    Wang, Xiangyu
    Han, Jiahao
    Zhang, Rui
    Chen, Zhenmei
    Li, Yitong
    Ma, Xiaochen
    Zhang, Guo
    Fan, Jie
    Chen, Jinhong
    JOURNAL OF SURGICAL ONCOLOGY, 2021, 124 (08) : 1431 - 1441
  • [5] Synchronous colorectal liver metastases: The importance of response to neoadjuvant chemotherapy
    Allen, P
    Jarnagin, W
    Kemeny, N
    Dematteo, R
    Blumgart, L
    Fong, Y
    GASTROENTEROLOGY, 2002, 123 (01) : 3 - 3
  • [6] Liver resection after neoadjuvant chemotherapy for unresectable colorectal metastases
    Noguera, J.
    Arrivi, A.
    Vicens, J.
    Morales, R.
    Ibarra, J.
    Dolz, C.
    Pujol, J.
    ANNALS OF ONCOLOGY, 2006, 17 : 57 - 57
  • [7] Complete pathological response of colorectal liver metastases after neoadjuvant chemotherapy: myth or reality?
    Wicherts, D. A.
    Haas de, R. J.
    Levi, F.
    Aloia, T.
    Paule, B.
    Bralet, M.
    Kunstlinger, F.
    Azoulay, D.
    Castaing, D.
    Adam, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [8] Detection and Viability of Colorectal Liver Metastases After Neoadjuvant Chemotherapy
    Dunet, Vincent
    Halkic, Nermin
    Prior, John O.
    Anaye, Anass
    Meuli, Reto A.
    Sempoux, Christine
    Denys, Alban
    Schmidt, Sabine
    CLINICAL NUCLEAR MEDICINE, 2017, 42 (04) : 258 - 263
  • [9] Pathological response grade of colorectal liver metastases treated with neoadjuvant chemotherapy
    Chan, Gabriel
    Hassanain, Mazen
    Chaudhury, Prosanto
    Vrochides, Dionisios
    Neville, Amy
    Cesari, Matthew
    Kavan, Petr
    Marcus, Victoria
    Metrakos, Peter
    HPB, 2010, 12 (04) : 277 - 284
  • [10] Importance of histologic tumor response to neoadjuvant chemotherapy in colorectal liver metastases
    Rubbia-Brandt, L.
    Giostra, E.
    Brezault, C.
    Roth, A.
    Andres, A.
    Majno, P.
    Soubrane, O.
    Chaussade, S.
    Mentha, G.
    Terris, B.
    ANNALS OF ONCOLOGY, 2006, 17 : 24 - 24